Stock Analiz

Vertex Pharmaceuticals Inc. / MA (VRTX) earnings: date, estimates and history

Price $538.60 · data as of November 13, 2026

Next earnings report

Next reportNot announced yet
Quarterending December 31, 2026
EPS estimate$4.10
Revenue estimate$3.5B
Expected EPS growth−18.4%

The date appears here once Vertex Pharmaceuticals Inc. / MA confirms it, usually two to four weeks before the report.

Track record

Beat EPS estimates2 of 4
Average surprise+2.0%
Average move on report day±1.6%

Vertex Pharmaceuticals Inc. / MA beat the consensus earnings estimate in 2 of its last 4 reports, by +2.0% on average. On report days the stock moved 1.6% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
November 2, 2026
Sep/2026
$4.78$4.76−0.5%$3.4B—−5.0%
August 3, 2026
Jun/2026
$4.75$4.73−0.3%$3.3B+12.5%+0.3%
May 4, 2026
Mar/2026
$4.31$4.47+3.8%$3.0B+7.8%+0.1%
November 3, 2025
Sep/2025
$4.58$4.80+4.9%$3.1B+11.0%−0.9%

EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is Vertex Pharmaceuticals Inc. / MA’s next earnings date?

Vertex Pharmaceuticals Inc. / MA has not confirmed its next report date yet. Its last report was on November 2, 2026.

Did Vertex Pharmaceuticals Inc. / MA beat earnings last quarter?

No, it reported EPS of $4.76 on November 2, 2026 against an estimate of $4.78 (a −0.5% surprise), and the stock moved −5.0% the next trading day.

What EPS do analysts expect next quarter?

The consensus estimate is $4.10 per share on revenue of about $3.5B.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar